CELLAVISION AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 233.2 SEK | -2.81% |
|
+5.00% | +8.96% |
| Feb. 07 | Transcript : CellaVision AB, Q4 2023 Earnings Call, Feb 07, 2024 | |
| Feb. 07 | CellaVision AB Proposes Dividend for the Year 2023 | CI |
Chart calendar CellaVision AB
9f92a45f7.aD1NKFl9U1WMhw7v1iLzrXFcb60bu6fBUydBPrEYy5A.Dk4oQQsXAGPF70_cjA-d-SU1Avo2yMKQYU4kS_xhgPkgED1CCQ8XH9r0Rw~b41262ae9ab434ee1f8a2cf5a79f2fba
Upcoming events on CellaVision AB
Past events on CellaVision AB
| Today 01:20 am | Q1 2024 Earnings Release |
| 2024-02-07 05:00 am | Q4 2023 Earnings Call |
| 2024-02-07 01:20 am | Q4 2023 Earnings Release |
| 2023-10-25 05:00 am | Q3 2023 Earnings Call |
| 2023-10-25 01:20 am | Q3 2023 Earnings Release |
| 2023-07-20 05:00 am | Q2 2023 Earnings Call |
| 2023-07-20 01:20 am | Q2 2023 Earnings Release |
| 2023-05-07 | Ex-dividend day for final dividend |
| 2023-05-05 09:00 am | Annual General Meeting |
| 2023-05-04 05:00 am | Q1 2023 Earnings Call |
| 2023-05-04 01:20 am | Q1 2023 Earnings Release |
| 2023-02-07 05:00 am | FY 2022 Earnings Call |
| 2023-02-07 01:20 am | FY 2022 Earnings Release |
| 2022-11-23 05:20 am | SEB Healthcare Seminar |
| 2022-11-16 | Carlsquare Nordic Life Science Investor Day |
| 2022-10-26 05:00 am | Q3 2022 Earnings Call |
| 2022-10-26 01:20 am | Q3 2022 Earnings Release |
| 2022-07-20 05:00 am | Interim 2022 Earnings Call |
| 2022-07-20 01:20 am | Interim 2022 Earnings Release |
| 2022-05-22 | Berenberg Bank USA Conference |
Past dividends on CellaVision AB
| 2023-05-07 | Annual 2.25 SEK |
| 2022-05-11 | Annual 2 SEK |
| 2021-04-29 | Annual 0.75 SEK |
| 2019-05-08 | Annual 1.5 SEK |
| 2018-05-06 | Annual 1.5 SEK |
| 2017-05-07 | Annual 1.5 SEK |
| 2016-05-05 | Annual 1.5 SEK |
| 2015-05-06 | 1 SEK |
| 2014-05-07 | Annual 0.5 SEK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 462 458 0.77% | 471 479 -1.62% | 566 563 0.38% | 639 674 -5.14% | 677 653 3.67% | 779 |
|
EBITDA Million SEK | Released Forecast Spread | 147 152 -3.49% | 143 143 0.26% | 196 184 6.48% | 198 205 -3.29% | 207 186 10.98% | 261 |
|
EBIT Million SEK | Released Forecast Spread | 127 139 -8.79% | 110 116 -5.19% | 163 157 3.42% | 158 168 -5.65% | 167 147 13.77% | 221 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 129 138 -6.57% | 112 114 -1.16% | 158 154 3% | 148 155 -3.93% | 164 142 15.71% | 220 |
|
Net income Million SEK | Released Forecast Spread | 99,2 109 -9.02% | 89,5 88,9 0.66% | 125 121 3.44% | 118 122 -3.27% | 130 112 16.38% | 174 |
|
EPS SEK | Released Forecast Spread | 4,16 4,57 -8.95% | 3,75 3,73 0.54% | 5,25 5,08 3.33% | 4,96 5,31 -6.57% | 5,46 4,72 15.72% | 7,28 |
| Announcement Date | 05/02/20 | 04/02/21 | 04/02/22 | 08/02/23 | 07/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 164 162 1.3% | 162 153 6.23% | 184 161 14.02% | 141 148 -4.97% | 152 190 -19.73% | 139 139 0.07% | 170 160 5.93% | 168 162 3.68% | 201 176 13.93% | 173 | 197 | 189 | 223 |
|
EBITDA Million SEK | Released Forecast Spread | 60,5 57,0 6.15% | 59,0 49,8 18.51% | 61,5 54,7 12.42% | 29,5 43,8 -32.72% | 48,4 62,2 -22.14% | 34,5 34,8 -0.68% | 56,0 50,8 10.23% | 43,4 51,9 -16.31% | 72,8 54,6 33.22% | 55,1 | 65,9 | 63,8 | 82,3 |
|
EBIT Million SEK | Released Forecast Spread | 51,8 46,4 11.59% | 49,8 41,1 21.23% | 52,4 45,5 15.21% | 17,0 34,7 -51.17% | 39,1 50,4 -22.51% | 25,0 25,5 -1.64% | 46,2 41,1 12.5% | 33,3 42,0 -20.72% | 62,6 44,3 41.2% | 45,7 | 55,8 | 54,2 | 72,2 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 51,0 46,4 9.93% | 48,6 40,0 21.6% | 46,9 44,5 5.26% | 12,9 33,7 -61.92% | 40,1 48,0 -16.42% | 24,4 24,6 -1.16% | 44,3 37,8 17.27% | 32,2 41,7 -22.87% | 63,4 48,2 31.35% | 44,2 | 54,9 | 52,1 | 74,4 |
|
Net income Million SEK | Released Forecast Spread | 39,8 36,6 8.68% | 38,4 31,7 20.96% | 37,3 35,3 5.38% | 10,4 26,8 -61.25% | 32,3 38,1 -15.27% | 19,2 19,6 -1.84% | 34,7 29,9 16.01% | 26,0 33,0 -21.4% | 50,4 33,7 49.43% | 34,4 | 43,3 | 41,7 | 56,5 |
|
EPS SEK | Released Forecast Spread | 1,67 1,54 8.33% | 1,61 1,33 20.95% | 1,56 1,48 5.26% | 0,44 1,12 -60.84% | 1,35 1,61 -16.38% | 0,81 0,82 -1.27% | 1,46 1,34 8.99% | 1,09 1,38 -21.1% | 2,11 1,37 53.86% | 1,55 | 1,88 | 1,78 | 2,39 |
| Announcement Date | 04/02/22 | 10/05/22 | 20/07/22 | 26/10/22 | 08/02/23 | 04/05/23 | 20/07/23 | 25/10/23 | 07/02/24 | - | - | - | - |
| 2024-04-28 | INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-28 | CONTEC MEDICAL SYSTEMS CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-28 | INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-02 04:05 pm | VAREX IMAGING CORPORATION: Q2 2024 Earnings Release |
| 2024-05-07 | QUIDELORTHO CORPORATION: Q1 2024 Earnings Release |
| 2024-07-15 | BIOTAGE AB: Q2 2024 Earnings Release |
| 2024-07-19 01:00 am | SARTORIUS AG: Q2 2024 Earnings Release |
| 2024-07-29 | VAREX IMAGING CORPORATION: Q3 2024 Earnings Release (Projected) |
| 2024-07-31 | QUIDELORTHO CORPORATION: Q2 2024 Earnings Release (Projected) |
| 2024-08-07 | REVENIO GROUP OYJ: Q2 2024 Earnings Release |
Past sector events for CellaVision AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CEVI Stock
- Calendar CellaVision AB
